s

Initiator Pharma

Initiator Pharma is a pharmaceutical company based in Aarhus, Denmark, established via a spin out from Saniona AB (listed on Nasdaq Stockholm First North Premier). The primary focus of the Company is the pharmaceutical candidate IPED2015, which constitutes a new treatment for the indication of erectile dysfunction (ED) – the inability of a man to achieve and maintain an erection and thus be able to complete sexual intercourse. Initiator Pharma’s new treatment method with IPED2015 is intended to treat the large group of patients suffering from erectile dysfunction who are resistant to current treatment methods.

Read more